1. Jefferson Institute of Molecular Medicine and Scleroderma Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
2. Clinical Development, Alumis Inc, San Francisco, California, USA
3. Immuno-Oncology and Cancer/iPSC/Cell Immunotherapy, Fate Therapeutics, San Diego, California, USA